BioCentury
ARTICLE | Company News

Aurelium, KS Biomedix deal

February 26, 2001 8:00 AM UTC

The companies will develop protein therapeutics to treat multi-drug resistant cancer. Aurelium will provide protein targets expressed on tumor cells that are resistant to a range of cancer drugs, and ...